Author:
Taprogge Jan,Murray Iain,Gear Jonathan,Chittenden Sarah J.,Parker Christopher C.,Flux Glenn D.
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference35 articles.
1. A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer;Nilsson;Eur J Cancer,2012
2. Alpha emitter radium-223 and survival in metastatic prostate cancer;Parker;N Engl J Med,2013
3. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): A randomised, double-blind, placebo-controlled, phase 3 trial;Smith;Lancet Oncol,2019
4. Radium-223 in the treatment of osteoblastic metastases: A critical clinical review;Humm;Int J Radiat Oncol Biol Phys,2015
5. Prostate cancer;Attard;Lancet,2016
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献